REBEL EM

SEPTEMBER 28, 2023

Paper: Van de Werf, F et al. STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial. References: Van de Werf, F et al. PMID: 37439219 Armstrong P et al. Primary PCI: 95.7% Primary PCI: 95.7%

STEMI 137

STEMI Allergic Reaction Coronary Ambulance 137

EMDocs

FEBRUARY 7, 2024

GLP-1 agonists are also associated with improved ejection fraction, coronary blood flow, and cardiac output while reducing the risk of cardiovascular events, infarction size, and all-cause mortality. Reactions are usually minor: transient warmth, pruritis at injection site that resolves. Shetty R, Basheer FT, Poojari PG, et al.

Allergic Reaction 97

Allergic Reaction ALS CAD OR 97

EMDocs

NOVEMBER 13, 2023

2 Outcomes of patients presenting with ischemic stroke who received MRI as initial imaging modality have demonstrated similar outcomes to those with initial CTA, with Kim et al. In a study of 17,903 CTAs ordered in the ED, Tu et al. 8 The data in Mayer et al. 9 A later assessment of the VAN score in Beume et al.

E-9-1-1 105

E-9-1-1 ALS Emergency Department ED 105